Uppsala Reports editor
The Identification of Medicinal Products (IDMP) standards promise to harmonise how pharmaceutical products and substances are described around the world. But how will that benefit patients and who will make sure the standards are properly implemented?
Uppsala Monitoring Centre’s Malin Fladvad and Olle Lagerlund join Drug Safety Matters host Federica Santoro to discuss the advantages and challenges of this global standardisation effort.
Subscribe by visiting the Drug Safety Matters website or listen in right here:
To find out even more about how IDMP will affect the future of pharmacovigilance – and what role UMC will play in that future – be sure to visit our information resources at: